Displaying all 2 publications

Abstract:
Sort:
  1. Farmers' attitudes towards GM crops and their predictors
    Mustapa MAC, Batcha MFN, Amin L, Arham AF, Mahadi Z, Yusoff NAM, et al.
    J Sci Food Agric, 2021 Oct;101(13):5457-5468.
    PMID: 33709409 DOI: 10.1002/jsfa.11194
    BACKGROUND: Genetically modified (GM) crops have become a controversial global issue since their commercialization in 1996. However, despite technological advancements, only a few studies have investigated farmers' attitudes towards GM crops in Malaysia. Therefore, this study aims to analyse such attitudes and their determining factors. A validated questionnaire was distributed to farmers in the Cameron Highlands, Pahang (n = 176). SPSS software was used to analyse the descriptive statistics of the farmers' attitudes to GM crops, while SmartPLS software was used to determine the predictors.

    RESULTS: Descriptive analysis shows that the farmers claimed to have a high level of self-efficacy, and perceived GM crops as possessing high benefits which translate into a highly positive attitude towards GM crops. However, at the same time, they rated GM crops as involving moderate risks and would incur moderate costs to farm, as well as acknowledging a low level of support from the government. The structural equation model (SEM) analysis demonstrates that five factors have been identified as direct predictors of attitude to GM crops: government support (ß = 0.364, P 

  2. Fulltext Prostate cancer in multi-ethnic Asian men: Real-world experience in the Malaysia Prostate Cancer (M-CaP) Study
    Lim J, Malek R, Jr S, Toh CC, Sundram M, Woo SYY, et al.
    Cancer Med, 2021 11;10(22):8020-8028.
    PMID: 34626088 DOI: 10.1002/cam4.4319
    Prostate cancer is the third most common cancer in Malaysia with the lifetime risk of 1 in 117 men. Here, we initiated a longitudinal Malaysia Prostate Cancer (M-CaP) Study to investigate the clinical and tumour characteristics, treatment patterns as well as disease outcomes of multi-ethnic Asian men at real-world setting. The M-CaP database consisted of 1839 new patients with prostate cancer diagnosed between 2016 and 2018 from nine public urology referral centres across Malaysia. Basic demographic and clinical parameters, tumour characteristics, primary treatment, follow-up and vital status data were retrieved prospectively from the hospital-based patients' case notes or electronic medical records. Primary endpoints were overall survival (OS) and biochemical progression-free survival (bPFS). The median age at diagnosis of M-CaP patients was 70 years (interquartile range, IQR 65-75). Majority of patients were Chinese (831, 45.2%), followed by Malays (704, 38.3%), Indians (124, 6.7%) and other races (181, 9.8%). The median follow-up for all patients was 23.5 months (IQR 15.9-33.6). Although 58.1% presented with late-stage cancer, we observed ethnic and geographic disparities in late-stage prostate cancer diagnosis. Curative radiotherapy and primary androgen deprivation therapy were the most common treatment for stage III and stage IV diseases, respectively. The median OS and bPFS of stage IV patients were 40.1 months and 19.2 months (95% CI 17.6-20.8), respectively. Late stage at presentation remains a challenge in multi-ethnic Asian men. Early detection is imperative to improve treatment outcome and survival of patients with prostate cancer.
Related Terms
    Try searching for something
Filters
Contact Us

Please provide feedback to Administrator ([email protected])

External Links